Disposable Syringes Market is estimated to be valued at USD 10 Bn in 2025 and is expected to reach USD 15.64 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of6.6% from 2025 to 2032.
The global market for disposable syringes is being propelled by an increased frequency of chronic diseases, underlying growth within pharmaceutical manufacturers, and an increased utilization of therapeutic injections. These reasons still supply the need for safe and one-time use injection systems. Take for instance, in January 2024, one of the global leaders in medical technology like Becton, Dickinson and Company (BD), announced the expansion of its syringe manufacturing facility in Nebraska, U.S. to address the rising global supply for pre-fillable syringes used in biologics and chronic disease medicines.
|
Event |
Description and Impact |
|
Advanced Needle Technology and Safety Innovation |
|
|
Healthcare Infrastructure Investment in Emerging Markets |
|
|
Global Supply Chain Disruptions and Raw Material Volatility |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The Safety Syringes segment is projected to hold the dominant position in the global disposable syringes market, commanding a significant 52.1% share in 2025. The sharp increase in market share can be linked to the growing use of safety-engineered injection devices in healthcare systems to minimize needlestick injuries and cross-infection.
Their adoption is now more prevalent in hospitals and clinics as well as in vaccination programs, especially due to stringent regulatory requirements and a greater emphasis on safety for both patients and healthcare workers.
Other important segments like conventional syringes still retain a significant share, particularly in more affordable and resource-limited regions where basic syringe products are still in demand. Even though these conventional syringes do not have any integrated safety features, they are inexpensive and well-known to healthcare professionals, which makes them widely used.
The market for safety syringes still dominates due to their adherence to international safety regulations and increased adoption for chronic illness management and immunizations; however, conventional syringes continue to be relevant in some geographies and applications. All these segments together constitute a well-rounded product landscape that serves various medical procedures and underscores the need for bespoke syringe solutions in the global healthcare system.
To learn more about this report, Download Free Sample
High usage rates among healthcare professionals increase the risk of needlestick injuries, prompting widespread adoption of safety-engineered syringe designs. According to a July 2022 article by StatPearls, billions of syringes are used annually across North America, reinforcing the critical need for safe, single-use devices to reduce transmission risks, particularly from hepatitis B and C.
Asia Pacific is witnessing rapid growth in the disposable syringes market, driven by expanding healthcare access, increasing vaccination programs, and rising patient populations. Countries such as China and India are investing heavily in public health infrastructure and adopting cost-effective, single-use medical devices to reduce infection rates. Government immunization initiatives and improvements in hospital care standards continue to propel regional demand.
Europe remains a significant market for disposable syringes, supported by its advanced healthcare systems and strict safety regulations. Growing awareness around infection prevention and the need for sterile medical practices fuel demand across hospitals and outpatient facilities. Regulatory focus on reducing healthcare-associated infections (HAIs) is also encouraging the use of auto-disable and safety syringes across the region.
The U.S. leads the North American market due to high chronic disease prevalence, a large volume of surgical procedures, and stringent healthcare safety protocols. Adoption of safety-engineered syringes to prevent needlestick injuries remains a key market driver.
India is a major contributor to Asia Pacific growth, driven by mass immunization programs, increasing healthcare spending, and local syringe manufacturing capabilities. Government initiatives for infection control continue to boost market demand.
Germany dominates the European market with its robust healthcare sector and adherence to EU medical safety standards. Emphasis on infection control and sustainable medical waste management supports continued adoption of disposable syringes.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 10 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.6% | 2032 Value Projection: | USD 15.64 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Major players operating in the global disposable syringes market include B. Braun SE, BD (Becton, Dickinson and Company), CODAN Medizinische Geräte GmbH, Gerresheimer AG, Medtronic, Retractable Technologies, Inc., Star Syringe Limited, ICU Medical, Inc., Terumo Corporation, and Sulzer Ltd. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Increasing inorganic growth strategies by market players is expected to propel growth of the global disposable syringes market over the forecast period. This is a strategic first step in building the larger partnership between the two companies and is in support of their recently announced collaboration. Through this distribution plan, Sharps Technology will be able to deliver increased capacity, driving growth for one of the high value product segments of our business. The agreement also allows for Sharps Technology to utilize Nephron's sales and marketing teams to further support the sale of the Company’s innovative products to targeted customers within the Nephron customer network.
According to CDC (Centers for Disease Control and Prevention), adults aged 65 years and above are more likely to acquire heart disease, COPS, diabetes, cancer, neurological problems, and other chronic illnesses. Patients with such illnesses require emergency and nonemergency hospital services which is expected to spur the market growth soon.
The increasing prevalence of chronic diseases is driving the demand for disposable syringes as a means of reducing the risk of needlestick injuries and blood borne pathogen exposure in both patients and healthcare workers.
Effective government policy such as awareness about the proper usage of needles, running campaigns for the safety measures, and so on is expected to drive the global safety needle market. For instance, in April 2022, American Medical Association (AMA) urges states to adopt new Maine needle, syringe exchange policy to modify restrictive laws and regulations concerning the sale and possession of needles and syringes to maximize the availability of sterile syringes and needle.
Share
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
